National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government Patent Portfolio Statistics

tip_user1

National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government

Profile Summary

This article summarizes the perfomance of the assignee in the recent years. The overall statistics for this portfolio help to analyze the areas where the assignee is performing well. The filing trend, perfomance across the tech centers and the perfomance of the recent applications has been mentioned below. All the stats are calculated based on the perfomance in USPTO.

How does the overall patent portfolio of National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government look like?

Assignee Art Units
Total Applications: 35,070 1,944,537
Granted Patents: 21,775 1,074,657
Grant Index 67.4% ↓ 69.66%
Abandoned/Rejected Applications: 10,534 (32.6%) 468,085 (30.34%)
In-Process Applications: 2,756 401,795
Average Grant Time: 3.39 Years ↑ 2.82 Years
Average Office Actions: 2.07 ↑ 1.66

Which Technology Area National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government is filing most patents in? (Last 10 years)

Art Unit Definition Total Applications
1644 Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology 1,204
1648 Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology 1,151
1634 Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry 1,144
1633 Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry 1,120
1632 Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry 1,068

How many patents are National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government filing every year?

Year Total Applications Predicted
2022 0* 1391
2021 4* 1347
2020 195 1182
2019 243 243
2018 844 –
2017 1,297 –
2016 1,510 –
2015 1,692 –
2014 2,175 –
2013 2,087 –

*The drop in the number of applications filed in last two years compared to previous years is because applications can take up to 18 months to get published

Recently filed patent applications of National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government in USPTO?

Publication number: None
Application number: 17/441,638

Abstract:
–

Publication date: –
Applicant: National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government
Inventors: Ikeda Tatsuhiko

Publication number: US20220170945A1
Application number: 17/442,069

Abstract:
The present invention provides: a method for assisting the evaluation of renal pathological conditions, said method comprising using, as an index, a combination of renal reabsorption and excretion ratios of D-serine and/or D-asparagine in a subject with the blood D-serine and/or D-asparagine levels; a system for evaluating renal pathological conditions; and a program for evaluating renal pathological conditions. The present invention also provides: a method for monitoring renal pathological conditions; and a method for monitoring an effect of treating a renal disease.

Publication date: 2022-06-02
Applicant: National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government
Inventors: Mita Masashi

Publication number: US20220127258A1
Application number: 17/310,432

Abstract:
The present invention relates to aromatic ring or heteroaromatic ring compounds, a preparation method therefor and a medical use thereof. Particularly, the present invention relates to a compound as shown in general formula (I) and a preparation method therefor, a pharmaceutical composition comprising the compound and a use thereof as an agonist for a farnesoid X receptor (FXR). The compound and the pharmaceutical composition comprising the compound can be used for treating and/or preventing FXR activity-related diseases, for example, cholestatic symptoms, diabetes and complications thereof, nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatosis heptitis (NASH), obesity or metabolic syndrome (diseases associated with dyslipidemia, diabetes, abnormally high body weight index), cardiovascular diseases and so on. The definition of each substituent in the general formula (I) is the same as that in the description.

Publication date: 2022-04-28
Applicant: National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government
Inventors: Hao Li

How are National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government’s applications performing in USPTO?

Application Number Title Status Art Unit Examiner
17/441,638 Method For Assisting Evaluation Of Condition Of Kidneys, System For Evaluating Condition Of Kidneys, And Program For Evaluating Condition Of Kidneys Docketed New Case – Ready for Examination OPAP Central, Docket
17/442,069 Method For Assisting Evaluation Of Renal Pathological Conditions, System For Evaluating Renal Pathological Conditions And Program For Evaluating Renal Pathological Conditions Docketed New Case – Ready for Examination OPAP Central, Docket
17/310,432 Aromatic Ring Or Heteroaromatic Ring Compounds, Preparation Method Therefor And Medical Use Thereof Docketed New Case – Ready for Examination OPAP Central, Docket
17/385,230 Vascular Anchoring Introducer Sheath Docketed New Case – Ready for Examination OPAP Central, Docket
17/344,627 Novel Th1-Inducing Adjuvant Comprising Combination Of Different Nucleic Acid Adjuvants, And Use Of Same Docketed New Case – Ready for Examination OPAP Central, Docket